Vaccine protocols for enhanced immunogenicity of exogenous antigens.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  International Journal of Medical Microbiology

• Publication date

  2008-01-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.IJMM.2007.08.004PMID 17888726
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CpG DNA in the Prevention and Treatment of Infections

  2012cited by this paper
• Immunostimulatory DNA sequences help to eradicate intracellular pathogens

  2009cited by this paper
• Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand

  2007cited by this paper
• Antigen co‐encapsulated with adjuvants efficiently drive protective T cell immunity

  2007cited by this paper
• Nucleotide-Binding Oligomerization Domain-Like Receptors: Intracellular Pattern Recognition Molecules for Pathogen Detection and Host Defense1

  2006cited by this paper
• U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7.

  2006cited by this paper
• Innate immune recognition of viral infection.

  2006cited by this paper
• Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA.

  2006cited by this paper
• Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems.

  2006cited by this paper
• Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.

  2006cited by this paper
• Innate immune recognition of viral infection

  2006cited by this paper
• All is not Toll: new pathways in DNA recognition

  2006cited by this paper
• Pathogen recognition and innate immunity.

  2006cited by this paper
• Dectin-1: a signalling non-TLR pattern-recognition receptor

  2006cited by this paper
• CpG motif‐independent activation of TLR9 upon endosomal translocation of “natural” phosphodiester DNA

  2006cited by this paper
• Signals required for programming effector and memory development by CD8+ T cells

  2006cited by this paper
• Endosomal Translocation of Vertebrate DNA Activates Dendritic Cells via TLR9-Dependent and -Independent Pathways 1

  2005cited by this paper
• RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement

  2005cited by this paper
• Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

  2005cited by this paper
• Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

  2005cited by this paper
• TLR3 and TLR7 Are Targeted to the Same Intracellular Compartments by Distinct Regulatory Elements*♦

  2005cited by this paper
• Signal 3 Tolerant CD8 T Cells Degranulate in Response to Antigen but Lack Granzyme B to Mediate Cytolysis1

  2005cited by this paper
• Cutting Edge: Type I IFNs Provide a Third Signal to CD8 T Cells to Stimulate Clonal Expansion and Differentiation1

  2005cited by this paper
• Protective CD8 T Cell Immunity Triggered by CpG-Protein Conjugates Competes with the Efficacy of Live Vaccines1

  2005cited by this paper
• Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration

  2004cited by this paper
• CpG-DNA Aided Cross-Priming by Cross-Presenting B Cells1

  2004cited by this paper
• Liposome-Encapsulated CpG Oligodeoxynucleotides as a Potent Adjuvant for Inducing Type 1 Innate Immunity

  2004cited by this paper
• Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8

  2004cited by this paper
• Microparticles for the delivery of DNA vaccines

  2004cited by this paper
• TLR9 signals after translocating from the ER to CpG DNA in the lysosome

  2004cited by this paper
• Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

  2003cited by this paper
• Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells

  2003cited by this paper
• Cutting Edge: Toll-Like Receptor 9 Expression Is Not Required for CpG DNA-Aided Cross-Presentation of DNA-Conjugated Antigens but Essential for Cross-Priming of CD8 T Cells1

  2003cited by this paper
• The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily

  2003cited by this paper
• The Roles of IL-12 in Providing a Third Signal for Clonal Expansion of Naive CD8 T Cells1

  2002cited by this paper
• Lipopolysaccharide Rapidly Traffics to and from the Golgi Apparatus with the Toll-like Receptor 4-MD-2-CD14 Complex in a Process That Is Distinct from the Initiation of Signal Transduction* 210

  2002cited by this paper
• Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

  2002cited by this paper
• Bacterial CpG‐DNA and lipopolysaccharides activate Toll‐like receptors at distinct cellular compartments

  2002cited by this paper
• CpG‐DNA aided cross‐presentation of soluble antigens by dendritic cells

  2002cited by this paper
• Novel Roles of CpG Oligodeoxynucleotides as a Leader for the Sampling and Presentation of CpG-Tagged Antigen by Dendritic Cells1

  2001cited by this paper
• Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism

  2000cited by this paper
• Bacterial DNA causes septic shock

  1997cited by this paper
• Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants

  1997cited by this paper
• Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor‐α‐mediated shock

  1997cited by this paper
• In interleukin‐4‐deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production

  1996cited by this paper
• MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates.

  1996cited by this paper
• Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis

  1994cited by this paper
• Class I-restricted processing and presentation of exogenous cell- associated antigen in vivo

  1990cited by this paper
• Antigen recognition. Class discrimination in the world of immunology.

  1987cited by this paper
• Class discrimination in the world of immunology

  1987cited by this paper

• Recent advancement, immune responses, and mechanism of action of various vaccines against intracellular bacterial infections.

  2022cites this paper
• Flt3-L enhances trans-epithelial migration and antigen presentation of dendritic cells adoptively transferred to genital mucosa.

  2020cites this paper
• Development of biomaterial porous scaffolds for dendritic cell modulation and mRNA delivery

  2017cites this paper
• Nanoparticle-Based Nicotine Vaccine

  2016cites this paper
• Molecular Detection of vanA and vanB Genes in Vancomycin-Resistant Enterococcus Isolated by Polymerase Chain Reaction From the Intestines of Children Admitted to the Intensive Care Units

  2014cites this paper
• Chemokine programming dendritic cell antigen response: part I – select chemokine programming of antigen uptake even after maturation

  2013cites this paper
• Status and future perspectives of vaccines for industrialised fin-fish farming.

  2013cites this paper
• In silico experiment with an-antigen-toll like receptor-5 agonist fusion construct for immunogenic application to Helicobacter pylori

  2013cites this paper
• Chemokine programming dendritic cell antigen response: part II – programming antigen presentation to T lymphocytes by partially maintaining immature dendritic cell phenotype

  2013cites this paper
• Uso de membranas bacterianas como fuente para la elaboración de liposomas como adyuvantes

  2012cites this paper
• PLGA and PLA particles as vaccine delivery systems for Atlantic salmon : a study on formulation and use with an emphasis on immune responses

  2012cites this paper
• Modulation of the Humoral Response to Dermatophagoides pteronyssinus Allergens in BALB/c Mice by Extract Modification and Adjuvant Use

  2011cites this paper
• Calcineurin subunit B activates dendritic cells and acts as a cancer vaccine adjuvant.

  2011cites this paper
• Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses

  2010influential citation
• Biodegradable microparticles as a single dose delivery system for Ehrlichia ruminantium vaccines

  2010cites this paper
• Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

  2010cites this paper
• ANALYSIS OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS ANTIGENS PRESENTATION BY MACROPHAGES

  2010cites this paper
• Preparation and in vitro characterisation of Ehrlichia ruminantium plasmid DNA and proteins encapsulated into and DNA adsorbed onto biodegradable microparticles.

  2010cites this paper
• Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly

  2010cites this paper
• Poly(I:C) coated PLGA microparticles induce dendritic cell maturation.

  2009cites this paper
• Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles.

  2009influential citation
• The stimulation of CD8+ T cells by dendritic cells pulsed with polyketal microparticles containing ion-paired protein antigen and poly(inosinic acid)-poly(cytidylic acid).

  2009cites this paper
• The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice.

  2009cites this paper
• DESARROLLO DEL PROCESO DE PRODUCCION DE LA PORINA OMPC DE SALMONELLA ENTERICA SEROVAR TYPHI PARA LA REALIZACION DE ESTUDIOS CLINICOS FASE I

  2009cites this paper
• Vaccines against intracellular bacterial pathogens.

  2008cites this paper
• Biodegradable polymeric delivery systems for protein subunit vaccines

  2008cites this paper